+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Demineralized Bone Matrix Market - Global Forecast to 2030- Product Image
Demineralized Bone Matrix Market - Global Forecast to 2030- Product Image
Sale

Demineralized Bone Matrix Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 182 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5968400
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Demineralized Bone Matrix Market grew from USD 713.36 million in 2024 to USD 762.74 million in 2025. It is expected to continue growing at a CAGR of 6.60%, reaching USD 1.04 billion by 2030.

The demineralized bone matrix (DBM) sector has emerged as a cornerstone of regenerative medicine, leveraging the natural osteoinductive properties of human bone to support skeletal repair. By removing the mineral component and preserving collagen and growth factors, DBM products facilitate new bone formation across a spectrum of clinical applications. This executive summary unpacks the critical drivers, market dynamics, and competitive forces shaping the DBM landscape. We explore how innovations in formulation-ranging from collagen-based gels to bioceramic-enriched putty with chips-are meeting growing demand from diverse end users, including ambulatory surgical centers, dental clinics, hospitals, and orthopedic practices. In parallel, the report examines the influence of regulatory environments, technological advances in minimally invasive procedures, and evolving surgical protocols on DBM adoption. With a focus on strategic growth and risk mitigation, we set the stage for an in-depth analysis of tariff impacts, segmentation insights, regional performance, and leading industry players. This introduction aims to equip decision-makers with a clear understanding of market scope, competitive positioning, and the transformative shifts redefining the future of demineralized bone matrix solutions.

Transformative Shifts Reshaping the Demineralized Bone Matrix Landscape

The past several years have witnessed transformative shifts in the DBM landscape, driven by technological innovation, changing clinical demands, and consolidation across the supply chain. Novel carrier materials, such as composite putty formulations and natural polymers, have enhanced osteoconductivity and handling characteristics, while collagen-based gels have gained traction for precise delivery in minimally invasive procedures. Digital planning platforms and intraoperative imaging are streamlining surgical workflows, enabling personalized graft placement and improved patient outcomes. Strategic alliances between biotech innovators and established medical device companies are accelerating product development and regulatory approvals. At the same time, manufacturers are integrating sustainability initiatives, from responsibly sourced allograft tissue to eco-friendly packaging. Regulatory harmonization efforts in key markets are lowering barriers to entry, fostering a more competitive environment. As a result, the DBM sector is shifting from commodity-driven pricing to value-based solutions, emphasizing clinical differentiation and long-term efficacy. These shifts underscore the need for agile strategies that balance innovation with cost management and regulatory compliance.

Assessing the 2025 US Tariffs Impact on Demineralized Bone Matrix Trade

The implementation of new US tariffs in 2025 has exerted significant pressure on global DBM supply chains and pricing structures. Import duties on bone graft substrates and ancillary components have elevated landed costs for products sourced from international suppliers, prompting many organizations to reassess vendor partnerships. In response, several manufacturers have accelerated investments in domestic tissue banks and autologous graft processing, reducing reliance on cross-border shipments and mitigating currency volatility. Pricing pressures have translated into tighter margins for providers, intensifying competition and compelling companies to justify value through clinical evidence and service offerings. Additionally, some distributors have absorbed part of the increased duty to preserve customer loyalty, while others have passed costs on, leading to variable pricing outcomes in different end-user segments. Despite these challenges, the tariff landscape has catalyzed innovation in supply-chain optimization, encouraging nearshoring strategies and strategic inventory positioning. As stakeholders adapt to the new cost paradigm, agility in sourcing and pricing models will be critical to sustaining growth and maintaining competitive advantage.

Key Segmentation Insights Driving Market Differentiation

A deep dive into product type segmentation reveals that collagen-based gels are particularly well suited for precision applications, offering high biocompatibility and ease of delivery in small-volume procedures. Composite putty formulations have secured a strong foothold in joint reconstruction and trauma surgery, blending synthetic polymers with demineralized material for optimal handling. Bioceramic-enriched putty with chips is emerging as a premium offering, leveraging enhanced osteoconductivity for complex spinal fusion cases. From an application perspective, the DBM market spans dental procedures, joint reconstruction, spinal fusion, and trauma surgery, with each segment exhibiting unique growth drivers-from aesthetic demands in maxillofacial grafting to load-bearing requirements in orthopedic repairs. Among end users, ambulatory surgical centers and dental clinics are capitalizing on minimally invasive approaches, while hospitals and orthopedic clinics continue to favor established open surgery protocols. Source segmentation highlights a dichotomy between allograft products-led by fibular allograft materials-and autologous grafts, each presenting distinct logistical and regulatory considerations. Material formulation trends point to a balanced demand for collagen-based and mineralized options, depending on clinical preference. Surgical approach analysis underscores the momentum behind minimally invasive surgery, even as open surgery maintains a substantial share. In procedure type, fracture repair, maxillofacial surgery, and spine fusion surgery each offer opportunities for tailored DBM solutions. Carrier type dynamics reveal parallel interest in natural polymers, prized for their biocompatibility, and synthetic polymers, valued for consistency and scalability.

Regional Dynamics Shaping Global Demineralized Bone Matrix Demand

Regional dynamics play a pivotal role in shaping global DBM demand. In the Americas, robust healthcare infrastructure and widespread reimbursement frameworks underpin strong uptake of advanced bone graft alternatives within hospitals and orthopedic clinics. Providers in this region are increasingly integrating collagen-based gels into minimally invasive surgical suites, while composite putty solutions address high-volume trauma centers. Across Europe, the Middle East & Africa, the market is characterized by regulatory diversity and varying degrees of public-private collaboration. Adoption is driven by private clinic networks in Western Europe, while emerging economies are witnessing gradual capacity building in spinal and orthopedic specialties. Government initiatives to modernize healthcare delivery are catalyzing interest in both allograft and autologous DBM offerings. In Asia-Pacific, rapid expansion of dental and trauma infrastructure, coupled with favorable policy reforms, is fueling uptake of bioceramic-enriched putty with chips for complex reconstructions. Local manufacturing partnerships and strategic joint ventures are accelerating market penetration, particularly in major metropolitan centers where demand for minimally invasive procedures is on the rise.

Leading Players Driving Innovation and Collaboration in DBM

Innovation and collaboration define the competitive landscape, with established players and agile challengers alike investing in next-generation DBM solutions. Advanced Biotech Products P Ltd is pioneering carrier systems that marry natural polymers with growth factors, while AlloSource and Arthrex, Inc. are forging partnerships to expand allograft processing capabilities. Bioventus LLC and Cerapedics.Inc. are at the forefront of composite and bioceramic-enriched technologies, respectively, leveraging clinical trial data to differentiate their offerings. Curasan AG and Exactech, Inc. are capitalizing on streamlined regulatory pathways in key markets, while Geistlich Pharma AG is broadening its footprint in Europe and the Middle East. Globus Medical and HansBioMed. are integrating digital preoperative planning tools, enhancing the precision of DBM placement. Institut Straumann AG and Integra LifeSciences Holdings Corporation are strengthening distribution networks through targeted acquisitions, and Johnson & Johnson Services, Inc. alongside Medtronic PLC are driving mergers and alliances to accelerate portfolio diversification. KLS Martin SE & Co. KG and Zimmer Biomet are optimizing surgical instrumentation to complement DBM products, while Kuros Biosciences Ltd. and NovaBone by Halma PLC are advancing bioengineered matrix platforms. Orthofix Medical Inc., Osteogenics Biomedical, RTI Surgical Holdings, Inc. and SpineWave, Inc. are refining spine fusion workflows, and Stryker Corporation and Synerheal are championing minimally invasive procedural kits. Meanwhile, XTANT Medical is exploring xenogeneic and synthetic scaffolds to broaden application horizons.

Actionable Recommendations for Demineralized Bone Matrix Industry Leaders

Industry leaders must adopt a proactive stance to capitalize on evolving market conditions. Prioritizing research and development for composite and bioceramic-enriched formulations will ensure product differentiation and clinical efficacy. Diversifying sourcing strategies-balancing allograft, autologous, and synthetic inputs-can mitigate tariff risks and supply interruptions. Optimizing supply chains through nearshoring and inventory management will reduce cost volatility and strengthen distribution resilience. Engaging early and frequently with regulatory bodies across key geographies will expedite approvals and foster compliance. Expanding partnerships with healthcare providers to co-develop service models can enhance the value proposition and reinforce customer loyalty. Leveraging digital platforms and AI-driven analytics will refine surgical planning, support data-driven marketing, and improve patient outcomes. Tailoring product offerings by procedure type and end-user preference-such as prioritizing gels for dental clinics and composite putty for trauma centers-will deepen market penetration. Finally, monitoring regional policies and reimbursement reforms will uncover emerging opportunities, particularly in high-growth Asia-Pacific markets.

Conclusion: Key Takeaways on Market Evolution

In conclusion, the demineralized bone matrix market stands at an inflection point, propelled by formulation innovations, procedural advances, and shifting regulatory landscapes. The implementation of new tariff measures has underscored the importance of supply-chain agility and diversified sourcing. Segmentation insights reveal distinct growth trajectories across product types, applications, end users, and carrier systems, guiding targeted strategies for market participants. Regional analysis highlights the Americas’ strong reimbursement environment, the diverse regulatory milieu of Europe, the Middle East & Africa, and the rapid expansion in Asia-Pacific surgical infrastructure. Leading companies are driving value through strategic collaborations, digital integration, and enhanced clinical evidence. By adopting the recommended actions-emphasizing R&D investment, regulatory engagement, and localized supply chains-stakeholders can navigate complexities and capture emerging opportunities. The evolving DBM landscape rewards those who combine innovation with operational excellence to deliver superior patient outcomes.

Market Segmentation & Coverage

This research report categorizes the Demineralized Bone Matrix Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Gels
    • Collagen-Based
  • Putty
    • Composite
  • Putty With Chips
    • Bioceramic-Enriched
  • Dental Procedures
  • Joint Reconstruction
  • Spinal Fusion
  • Trauma Surgery
  • Ambulatory Surgical Centers
  • Dental Clinics
  • Hospitals
  • Orthopedic Clinics
  • Allograft
    • Fibular
  • Autologous
  • Collagen-Based
  • Mineralized
  • Minimally Invasive Surgery
  • Open Surgery
  • Fracture Repair
  • Maxillofacial Surgery
  • Spine Fusion Surgery
  • Natural Polymer
  • Synthetic Polymer

This research report categorizes the Demineralized Bone Matrix Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Demineralized Bone Matrix Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Advanced Biotech Products P Ltd
  • AlloSource
  • Arthrex, Inc.
  • Bioventus LLC
  • Cerapedics.Inc.
  • Curasan AG
  • Exactech, Inc.
  • Geistlich Pharma AG
  • Globus Medical
  • HansBioMed.
  • Institut Straumann AG
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • KLS Martin SE & Co. KG
  • Kuros Biosciences Ltd.
  • Medtronic PLC
  • NovaBone by Halma PLC
  • Orthofix Medical Inc.
  • Osteogenics Biomedical
  • RTI Surgical Holdings, Inc.
  • SpineWave, Inc.
  • Stryker Corporation
  • Synerheal
  • XTANT Medical
  • Zimmer Biomet

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Demineralized Bone Matrix Market, by Product Type
8.1. Introduction
8.2. Gels
8.2.1. Collagen-Based
8.3. Putty
8.3.1. Composite
8.4. Putty With Chips
8.4.1. Bioceramic-Enriched
9. Demineralized Bone Matrix Market, by Application
9.1. Introduction
9.2. Dental Procedures
9.3. Joint Reconstruction
9.4. Spinal Fusion
9.5. Trauma Surgery
10. Demineralized Bone Matrix Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Dental Clinics
10.4. Hospitals
10.5. Orthopedic Clinics
11. Demineralized Bone Matrix Market, by Source
11.1. Introduction
11.2. Allograft
11.2.1. Fibular
11.3. Autologous
12. Demineralized Bone Matrix Market, by Material Formulation
12.1. Introduction
12.2. Collagen-Based
12.3. Mineralized
13. Demineralized Bone Matrix Market, by Surgical Approach
13.1. Introduction
13.2. Minimally Invasive Surgery
13.3. Open Surgery
14. Demineralized Bone Matrix Market, by Procedure Type
14.1. Introduction
14.2. Fracture Repair
14.3. Maxillofacial Surgery
14.4. Spine Fusion Surgery
15. Demineralized Bone Matrix Market, by Carrier Type
15.1. Introduction
15.2. Natural Polymer
15.3. Synthetic Polymer
16. Americas Demineralized Bone Matrix Market
16.1. Introduction
16.2. Argentina
16.3. Brazil
16.4. Canada
16.5. Mexico
16.6. United States
17. Asia-Pacific Demineralized Bone Matrix Market
17.1. Introduction
17.2. Australia
17.3. China
17.4. India
17.5. Indonesia
17.6. Japan
17.7. Malaysia
17.8. Philippines
17.9. Singapore
17.10. South Korea
17.11. Taiwan
17.12. Thailand
17.13. Vietnam
18. Europe, Middle East & Africa Demineralized Bone Matrix Market
18.1. Introduction
18.2. Denmark
18.3. Egypt
18.4. Finland
18.5. France
18.6. Germany
18.7. Israel
18.8. Italy
18.9. Netherlands
18.10. Nigeria
18.11. Norway
18.12. Poland
18.13. Qatar
18.14. Russia
18.15. Saudi Arabia
18.16. South Africa
18.17. Spain
18.18. Sweden
18.19. Switzerland
18.20. Turkey
18.21. United Arab Emirates
18.22. United Kingdom
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. Advanced Biotech Products P Ltd
19.3.2. AlloSource
19.3.3. Arthrex, Inc.
19.3.4. Bioventus LLC
19.3.5. Cerapedics.Inc.
19.3.6. Curasan AG
19.3.7. Exactech, Inc.
19.3.8. Geistlich Pharma AG
19.3.9. Globus Medical
19.3.10. HansBioMed.
19.3.11. Institut Straumann AG
19.3.12. Integra LifeSciences Holdings Corporation
19.3.13. Johnson & Johnson Services, Inc.
19.3.14. KLS Martin SE & Co. KG
19.3.15. Kuros Biosciences Ltd.
19.3.16. Medtronic PLC
19.3.17. NovaBone by Halma PLC
19.3.18. Orthofix Medical Inc.
19.3.19. Osteogenics Biomedical
19.3.20. RTI Surgical Holdings, Inc.
19.3.21. SpineWave, Inc.
19.3.22. Stryker Corporation
19.3.23. Synerheal
19.3.24. XTANT Medical
19.3.25. Zimmer Biomet
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. DEMINERALIZED BONE MATRIX MARKET MULTI-CURRENCY
FIGURE 2. DEMINERALIZED BONE MATRIX MARKET MULTI-LANGUAGE
FIGURE 3. DEMINERALIZED BONE MATRIX MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY MATERIAL FORMULATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY MATERIAL FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY SURGICAL APPROACH, 2024 VS 2030 (%)
FIGURE 18. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY SURGICAL APPROACH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
FIGURE 20. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY CARRIER TYPE, 2024 VS 2030 (%)
FIGURE 22. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY CARRIER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 26. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. DEMINERALIZED BONE MATRIX MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 32. DEMINERALIZED BONE MATRIX MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DEMINERALIZED BONE MATRIX MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY COLLAGEN-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY COMPOSITE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY WITH CHIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY BIOCERAMIC-ENRICHED, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY WITH CHIPS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY DENTAL PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY JOINT RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY TRAUMA SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY ALLOGRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY FIBULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY MATERIAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY COLLAGEN-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY MINERALIZED, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY FRACTURE REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY MAXILLOFACIAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY SPINE FUSION SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY CARRIER TYPE, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY NATURAL POLYMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY SYNTHETIC POLYMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY WITH CHIPS, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY MATERIAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY CARRIER TYPE, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY WITH CHIPS, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY MATERIAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY CARRIER TYPE, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL DEMINERALIZED BONE MATRIX MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY WITH CHIPS, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL DEMINERALIZED BONE MATRIX MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL DEMINERALIZED BONE MATRIX MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL DEMINERALIZED BONE MATRIX MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL DEMINERALIZED BONE MATRIX MARKET SIZE, BY MATERIAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL DEMINERALIZED BONE MATRIX MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL DEMINERALIZED BONE MATRIX MARKET SIZE, BY CARRIER TYPE, 2018-2030 (USD MILLION)
TABLE 81. CANADA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 82. CANADA DEMINERALIZED BONE MATRIX MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 83. CANADA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 84. CANADA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY WITH CHIPS, 2018-2030 (USD MILLION)
TABLE 85. CANADA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. CANADA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. CANADA DEMINERALIZED BONE MATRIX MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 88. CANADA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 89. CANADA DEMINERALIZED BONE MATRIX MARKET SIZE, BY MATERIAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 90. CANADA DEMINERALIZED BONE MATRIX MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 91. CANADA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 92. CANADA DEMINERALIZED BONE MATRIX MARKET SIZE, BY CARRIER TYPE, 2018-2030 (USD MILLION)
TABLE 93. MEXICO DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. MEXICO DEMINERALIZED BONE MATRIX MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 95. MEXICO DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 96. MEXICO DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY WITH CHIPS, 2018-2030 (USD MILLION)
TABLE 97. MEXICO DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. MEXICO DEMINERALIZED BONE MATRIX MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. MEXICO DEMINERALIZED BONE MATRIX MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 100. MEXICO DEMINERALIZED BONE MATRIX MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 101. MEXICO DEMINERALIZED BONE MATRIX MARKET SIZE, BY MATERIAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 102. MEXICO DEMINERALIZED BONE MATRIX MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 103. MEXICO DEMINERALIZED BONE MATRIX MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 104. MEXICO DEMINERALIZED BONE MATRIX MARKET SIZE, BY CARRIER TYPE, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY WITH CHIPS, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY MATERIAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY CARRIER TYPE, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 118. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 120. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY WITH CHIPS, 2018-2030 (USD MILLION)
TABLE 122. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 126. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY MATERIAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 127. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 128. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 129. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY CARRIER TYPE, 2018-2030 (USD MILLION)
TABLE 130. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 131. AUSTRALIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 132. AUSTRALIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 133. AUSTRALIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 134. AUSTRALIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY WITH CHIPS, 2018-2030 (USD MILLION)
TABLE 135. AUSTRALIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. AUSTRALIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. AUSTRALIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 138. AUSTRALIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 139. AUSTRALIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY MATERIAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 140. AUSTRALIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 141. AUSTRALIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 142. AUSTRALIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY CARRIER TYPE, 2018-2030 (USD MILLION)
TABLE 143. CHINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 144. CHINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 145. CHINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 146. CHINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY WITH CHIPS, 2018-2030 (USD MILLION)
TABLE 147. CHINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. CHINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. CHINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 150. CHINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 151. CHINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY MATERIAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 152. CHINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 153. CHINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 154. CHINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY CARRIER TYPE, 2018-2030 (USD MILLION)
TABLE 155. INDIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 156. INDIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 157. INDIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 158. INDIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY WITH CHIPS, 2018-2030 (USD MILLION)
TABLE 159. INDIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. INDIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. INDIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 162. INDIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 163. INDIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY MATERIAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 164. INDIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 165. INDIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 166. INDIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY CARRIER TYPE, 2018-2030 (USD MILLION)
TABLE 167. INDONESIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 168. INDONESIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 169. INDONESIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 170. INDONESIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY WITH CHIPS, 2018-2030 (USD MILLION)
TABLE 171. INDONESIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. INDONESIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. INDONESIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 174. INDONESIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 175. INDONESIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY MATERIAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 176. INDONESIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 177. INDONESIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 178. INDONESIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY CARRIER TYPE, 2018-2030 (USD MILLION)
TABLE 179. JAPAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 180. JAPAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 181. JAPAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 182. JAPAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY WITH CHIPS, 2018-2030 (USD MILLION)
TABLE 183. JAPAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. JAPAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. JAPAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 186. JAPAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 187. JAPAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY MATERIAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 188. JAPAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 189. JAPAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 190. JAPAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY CARRIER TYPE, 2018-2030 (USD MILLION)
TABLE 191. MALAYSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 192. MALAYSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 193. MALAYSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 194. MALAYSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY WITH CHIPS, 2018-2030 (USD MILLION)
TABLE 195. MALAYSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. MALAYSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. MALAYSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 198. MALAYSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 199. MALAYSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY MATERIAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 200. MALAYSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 201. MALAYSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 202. MALAYSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY CARRIER TYPE, 2018-2030 (USD MILLION)
TABLE 203. PHILIPPINES DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. PHILIPPINES DEMINERALIZED BONE MATRIX MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 205. PHILIPPINES DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 206. PHILIPPINES DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY WITH CHIPS, 2018-2030 (USD MILLION)
TABLE 207. PHILIPPINES DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. PHILIPPINES DEMINERALIZED BONE MATRIX MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. PHILIPPINES DEMINERALIZED BONE MATRIX MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 210. PHILIPPINES DEMINERALIZED BONE MATRIX MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 211. PHILIPPINES DEMINERALIZED BONE MATRIX MARKET SIZE, BY MATERIAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 212. PHILIPPINES DEMINERALIZED BONE MATRIX MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 213. PHILIPPINES DEMINERALIZED BONE MATRIX MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 214. PHILIPPINES DEMINERALIZED BONE MATRIX MARKET SIZE, BY CARRIER TYPE, 2018-2030 (USD MILLION)
TABLE 215. SINGAPORE DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 216. SINGAPORE DEMINERALIZED BONE MATRIX MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 217. SINGAPORE DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 218. SINGAPORE DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY WITH CHIPS, 2018-2030 (USD MILLION)
TABLE 219. SINGAPORE DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. SINGAPORE DEMINERALIZED BONE MATRIX MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. SINGAPORE DEMINERALIZED BONE MATRIX MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 222. SINGAPORE DEMINERALIZED BONE MATRIX MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 223. SINGAPORE DEMINERALIZED BONE MATRIX MARKET SIZE, BY MATERIAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 224. SINGAPORE DEMINERALIZED BONE MATRIX MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 225. SINGAPORE DEMINERALIZED BONE MATRIX MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 226. SINGAPORE DEMINERALIZED BONE MATRIX MARKET SIZE, BY CARRIER TYPE, 2018-2030 (USD MILLION)
TABLE 227. SOUTH KOREA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 228. SOUTH KOREA DEMINERALIZED BONE MATRIX MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 229. SOUTH KOREA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 230. SOUTH KOREA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY WITH CHIPS, 2018-2030 (USD MILLION)
TABLE 231. SOUTH KOREA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. SOUTH KOREA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. SOUTH KOREA DEMINERALIZED BONE MATRIX MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 234. SOUTH KOREA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 235. SOUTH KOREA DEMINERALIZED BONE MATRIX MARKET SIZE, BY MATERIAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 236. SOUTH KOREA DEMINERALIZED BONE MATRIX MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 237. SOUTH KOREA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 238. SOUTH KOREA DEMINERALIZED BONE MATRIX MARKET SIZE, BY CARRIER TYPE, 2018-2030 (USD MILLION)
TABLE 239. TAIWAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 240. TAIWAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 241. TAIWAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 242. TAIWAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY WITH CHIPS, 2018-2030 (USD MILLION)
TABLE 243. TAIWAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. TAIWAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. TAIWAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 246. TAIWAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 247. TAIWAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY MATERIAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 248. TAIWAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 249. TAIWAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 250. TAIWAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY CARRIER TYPE, 2018-2030 (USD MILLION)
TABLE 251. THAILAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 252. THAILAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 253. THAILAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 254. THAILAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY WITH CHIPS, 2018-2030 (USD MILLION)
TABLE 255. THAILAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. THAILAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. THAILAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 258. THAILAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 259. THAILAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY MATERIAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 260. THAILAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 261. THAILAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 262. THAILAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY CARRIER TYPE, 2018-2030 (USD MILLION)
TABLE 263. VIETNAM DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 264. VIETNAM DEMINERALIZED BONE MATRIX MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 265. VIETNAM DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 266. VIETNAM DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY WITH CHIPS, 2018-2030 (USD MILLION)
TABLE 267. VIETNAM DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 268. VIETNAM DEMINERALIZED BONE MATRIX MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. VIETNAM DEMINERALIZED BONE MATRIX MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 270. VIETNAM DEMINERALIZED BONE MATRIX MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 271. VIETNAM DEMINERALIZED BONE MATRIX MARKET SIZE, BY MATERIAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 272. VIETNAM DEMINERALIZED BONE MATRIX MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 273. VIETNAM DEMINERALIZED BONE MATRIX MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 274. VIETNAM DEMINERALIZED BONE MATRIX MARKET SIZE, BY CARRIER TYPE, 2018-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY WITH CHIPS, 2018-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY MATERIAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY CARRIER TYPE, 2018-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 288. DENMARK DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 289. DENMARK DEMINERALIZED BONE MATRIX MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 290. DENMARK DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 291. DENMARK DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY WITH CHIPS, 2018-2030 (USD MILLION)
TABLE 292. DENMARK DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 293. DENMARK DEMINERALIZED BONE MATRIX MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. DENMARK DEMINERALIZED BONE MATRIX MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 295. DENMARK DEMINERALIZED BONE MATRIX MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 296. DENMARK DEMINERALIZED BONE MATRIX MARKET SIZE, BY MATERIAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 297. DENMARK DEMINERALIZED BONE MATRIX MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 298. DENMARK DEMINERALIZED BONE MATRIX MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 299. DENMARK DEMINERALIZED BONE MATRIX MARKET SIZE, BY CARRIER TYPE, 2018-2030 (USD MILLION)
TABLE 300. EGYPT DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 301. EGYPT DEMINERALIZED BONE MATRIX MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 302. EGYPT DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 303. EGYPT DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY WITH CHIPS, 2018-2030 (USD MILLION)
TABLE 304. EGYPT DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 305. EGYPT DEMINERALIZED BONE MATRIX MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 306. EGYPT DEMINERALIZED BONE MATRIX MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 307. EGYPT DEMINERALIZED BONE MATRIX MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 308. EGYPT DEMINERALIZED BONE MATRIX MARKET SIZE, BY MATERIAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 309. EGYPT DEMINERALIZED BONE MATRIX MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 310. EGYPT DEMINERALIZED BONE MATRIX MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 311. EGYPT DEMINERALIZED BONE MATRIX MARKET SIZE, BY CARRIER TYPE, 2018-2030 (USD MILLION)
TABLE 312. FINLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 313. FINLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 314. FINLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 315. FINLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY WITH CHIPS, 2018-2030 (USD MILLION)
TABLE 316. FINLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 317. FINLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 318. FINLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 319. FINLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 320. FINLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY MATERIAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 321. FINLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 322. FINLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 323. FINLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY CARRIER TYPE, 2018-2030 (USD MILLION)
TABLE 324. FRANCE DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 325. FRANCE DEMINERALIZED BONE MATRIX MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 326. FRANCE DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 327. FRANCE DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY WITH CHIPS, 2018-2030 (USD MILLION)
TABLE 328. FRANCE DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICAT

Companies Mentioned

  • Advanced Biotech Products P Ltd
  • AlloSource
  • Arthrex, Inc.
  • Bioventus LLC
  • Cerapedics.Inc.
  • Curasan AG
  • Exactech, Inc.
  • Geistlich Pharma AG
  • Globus Medical
  • HansBioMed.
  • Institut Straumann AG
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • KLS Martin SE & Co. KG
  • Kuros Biosciences Ltd.
  • Medtronic PLC
  • NovaBone by Halma PLC
  • Orthofix Medical Inc.
  • Osteogenics Biomedical
  • RTI Surgical Holdings, Inc.
  • SpineWave, Inc.
  • Stryker Corporation
  • Synerheal
  • XTANT Medical
  • Zimmer Biomet

Methodology

Loading
LOADING...

Related Topics

Related Reports

Demineralized Bone Matrix Market Size, Share And Trends Analysis Report, By Product (Putty, Fiber, Paste), By Application (Spinal Fusion, Dental, Joint Reconstruction), By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Demineralized Bone Matrix Market Size, Share And Trends Analysis Report, By Product (Putty, Fiber, Paste), By Application (Spinal Fusion, Dental, Joint Reconstruction), By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Demineralized Bone Matrix - Global Strategic Business Report - Product Image

Demineralized Bone Matrix - Global Strategic Business Report

  • Report
  • 396 Pages
  • Global
From
Orthopedic Bone Graft Substitute Market Size, Share, and Trends Analysis | Global | 2025-2031 | MedCore | Includes: Allograft Market, Demineralized Bone Matrix Market, and 1 more - Product Image

Orthopedic Bone Graft Substitute Market Size, Share, and Trends Analysis | Global | 2025-2031 | MedCore | Includes: Allograft Market, Demineralized Bone Matrix Market, and 1 more

  • Report
  • 118 Pages
  • Global
From
Demineralized Bone Matrix Market 2025-2029 - Product Image

Demineralized Bone Matrix Market 2025-2029

  • Report
  • 200 Pages
  • Global
From
Demineralized Bone Fiber Technology Market - Global Forecast to 2030 - Product Image

Demineralized Bone Fiber Technology Market - Global Forecast to 2030

  • Report
  • 182 Pages
  • Global
From

About the Demineralized Bone Matrix Market

The Demineralized Bone Matrix (DBM) market is a subset of the larger biomaterials industry. DBM is a type of bone graft material that is used to repair and regenerate bone tissue. It is composed of collagen and other proteins, and is processed to remove the mineral content. DBM is used in a variety of orthopedic and dental procedures, including spinal fusion, fracture repair, and dental implantation. It is also used in reconstructive surgery, such as facial reconstruction. DBM is a growing market, with increasing demand for its use in a variety of medical procedures. It is a cost-effective alternative to autografts, and is gaining popularity due to its biocompatibility and ability to promote bone regeneration. Some companies in the DBM market include Zimmer Biomet, Medtronic, Stryker, and Orthofix. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.